MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
CELU — Celularity Inc. Class A Common Stock
NasdaqCelularity Inc. Class A Common Stock
$1.60
+0.22(+15.94%)
- O
- 1.37
- H
- 1.64
- L
- 1.36
- V
- 219.99K
⏱️ End-of-day dataAs of Oct 2, 2026
Chart
About CELU
Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.
IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateJul 19, 2021
Employees115
Stock ExchangeNasdaq
Ticker SymbolCELU
Websitehttps://www.celularity.com
Key Financial Statistics
| Market Cap | $39.95M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $0.56 - $2.55 |
| 52-Week Avg Volume | 1.09M |
| VWAP | $1.55 |
| Transactions | 1,433 |
| Total Recorded Bars | 1,798 days |